93 related articles for article (PubMed ID: 11070940)
21. [Acute lymphoblastic leukemia in childhood treated with non-T-cell depleted bone marrow transplantation from an HLA 2 loci (HLA-A and-DRB1)-mismatched mother after early graft failure of cord blood transplantation].
Ishida H; Mori K; Yoshihara T; Shin N; Morimoto A; Imashuku S
Rinsho Ketsueki; 2003 Nov; 44(11):1101-6. PubMed ID: 14689875
[TBL] [Abstract][Full Text] [Related]
22. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
[TBL] [Abstract][Full Text] [Related]
23. Successful non-T cell-depleted HLA haplo-identical three-loci mismatched hematopoietic stem cell transplantation from mother to son based on the feto-maternal microchimerism in chronic myelogenous leukemia.
Ochiai N; Shimazaki C; Fuchida S; Okano A; Sumikuma T; Ashihara E; Inaba T; Fujita N; Maruya E; Nakagawa M
Bone Marrow Transplant; 2002 Dec; 30(11):793-6. PubMed ID: 12439703
[TBL] [Abstract][Full Text] [Related]
24. Reconstitution of the CD45RO(+) and CD20(+) lymphoid marrow population following allogeneic bone marrow transplantation for Ph(+) CML.
Thiele J; Kvasnicka HM; Beelen DW; Welter A; Schneider S; Leder LD; Schaefer UW
Bone Marrow Transplant; 2001 Feb; 27(4):425-31. PubMed ID: 11313672
[TBL] [Abstract][Full Text] [Related]
25. Marrow aplasia developing 13 years after HLA-identical sibling allogeneic transplantation for chronic myeloid leukaemia: successful treatment with antithymocyte globulin and peripheral blood stem cell infusion from the original donor.
O'Donghaile D; Hayden PJ; McCarron SL; Doyle EM; Lawler M; Browne PV; Conneally E; Vandenberghe E; McCann SR
Eur J Haematol; 2006 Mar; 76(3):258-60. PubMed ID: 16451399
[TBL] [Abstract][Full Text] [Related]
26. [Bone marrow transplantation from an unrelated donor in patient with congenital heart diseases].
Kumazaki H; Hanada R; Kikuchi A; Ichikawa M; Yamamoto K; Aoyagi H
Rinsho Ketsueki; 1996 Aug; 37(8):731-3. PubMed ID: 8827886
[TBL] [Abstract][Full Text] [Related]
27. [HLA-identical sibling allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia in first chronic phase. Analysis of 51 cases].
He Y; Feng SZ; Wang M; Wei JL; Qin TJ; Zhou Z; Zhai WJ; Qiu LG; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2005 Jul; 26(7):389-92. PubMed ID: 16251016
[TBL] [Abstract][Full Text] [Related]
28. Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia.
Lee JH; Choi SJ; Lee JH; Lee YS; Seol M; Ryu SG; Lee JS; Kim WK; Lee KH
Bone Marrow Transplant; 2005 Apr; 35(8):755-61. PubMed ID: 15735661
[TBL] [Abstract][Full Text] [Related]
29. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
[TBL] [Abstract][Full Text] [Related]
30. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Ball E; Cook D; Andresen S; Kuczkowski E; Bolwell B
Bone Marrow Transplant; 2005 Feb; 35(3):247-52. PubMed ID: 15580282
[TBL] [Abstract][Full Text] [Related]
31. No significant association between HA-1 incompatibility and incidence of acute graft-versus-host disease after HLA-identical sibling bone marrow transplantation in Japanese patients.
Murata M; Emi N; Hirabayashi N; Hamaguchi M; Goto S; Wakita A; Tanimoto M; Saito H; Kodera Y; Morishita Y;
Int J Hematol; 2000 Oct; 72(3):371-5. PubMed ID: 11185997
[TBL] [Abstract][Full Text] [Related]
32. Influence of CD34(+) marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia.
Morariu-Zamfir R; Rocha V; Devergie A; Socié G; Ribaud P; Esperou H; Parquet N; Guardiola P; Dal Cortivo L; Bittencourt H; Garnier F; Traineau R; Marolleau JP; Chevret S; Gluckman E
Bone Marrow Transplant; 2001 Mar; 27(6):575-80. PubMed ID: 11319585
[TBL] [Abstract][Full Text] [Related]
33. [Second transplant from the same donor without conditioning for bone marrow aplasia after non-myeloablative hematopoietic stem cell transplantation for chronic myeloid leukemia].
Ishikawa I; Miyamura K; Yamada M; Sasaki O; Harigae H; Kameoka J; Meguro K; Sasaki T
Rinsho Ketsueki; 2005 Dec; 46(12):1288-92. PubMed ID: 16447801
[TBL] [Abstract][Full Text] [Related]
34. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
[TBL] [Abstract][Full Text] [Related]
35. Facilitated engraftment by intramedullary administered enriched allogeneic CD34+ cells?
Yano M; Watanabe A; Kawano Y; Watanabe T; Takaue Y
Bone Marrow Transplant; 1999 Apr; 23(8):847-8. PubMed ID: 10231152
[TBL] [Abstract][Full Text] [Related]
36. Extramedullary T cell lymphoblastic transformation of chronic myeloid leukaemia successfully treated with matched unrelated donor bone marrow transplantation.
Apfelbeck U; Hoefler G; Neumeister P; Fonatsch C; Linkesch W; Sill H
Bone Marrow Transplant; 2000 Nov; 26(10):1111-2. PubMed ID: 11108312
[TBL] [Abstract][Full Text] [Related]
37. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
[TBL] [Abstract][Full Text] [Related]
38. Allogeneic bone marrow transplantation of chronic myeloid leukemia from an HLA-matched unrelated donor with the beta-thalassemic trait.
Sue YC; Liu TC; Chang CS; Huang SM; Chen TP; Lin SF
Int J Hematol; 1999 Apr; 69(3):200-2. PubMed ID: 10222660
[TBL] [Abstract][Full Text] [Related]
39. Appearance of an inherited porphyria cutanea tarda in a child after allogeneic bone marrow transplantation for chronic myelogenous leukaemia.
Dopfer R; Doss M; Ehninger G; Ostendorf P; Niethammer D
Bone Marrow Transplant; 1986 May; 1(1):95-9. PubMed ID: 3332125
[TBL] [Abstract][Full Text] [Related]
40. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
